Skip to main content
. 2023 Apr 26;19(3):217–229. doi: 10.3988/jcn.2022.0208

Table 2. Low-, moderate-, and high-efficacy treatments for multiple sclerosis56.

Low-efficacy treatments Moderate-efficacy treatments High-efficacy treatments
• Interferons • Cladribine* • Ocrelizumab
• Glatiramer acetate • s1p inhibitors* • Ofatumumab
• Teriflunomide • Fumarates • Natalizumab
• Alemtuzumab

*May be considered to have moderate-to-high efficacy.